Launched on June 23, 2005, the Invesco Biotechnology & Genome ETF (ticker PBE) is a passively managed exchange traded fund. It is designed to provide broad exposure to the Healthcare - Biotech segment of the equity market.
Launched on June 23, 2005, the Invesco Biotechnology & Genome ETF (ticker PBE) is a passively managed exchange traded fund. It is designed to provide broad exposure to the Healthcare - Biotech segment of the equity market.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
neutral
Sentiment Score
0.00
Ticker Sentiment
